Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI Registry

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:71

Article

Singh, Avinainder^1,2  Collins, Bradley L.^1,2  Gupta, Ankur^1,2  Fatima, Amber³  Qamar, Arman⁴  Biery, David^1,2  Baez, Julio^1,2  Cawley, Mary^1,2  Klein, Josh^1,2  Hainer, Jon^1,2  Plutzky, Jorge⁴  Cannon, Christopher P.⁴  Nasir, Khurram⁵  Di Carli, Marcelo F.^1,2  Bhatt, Deepak L.⁴  Blankstein, Ron^1,2 

[1] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Imaging Program, Dept Med, Boston, MA USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Imaging Program, Dept Radiol, Boston, MA USA

[3] Tufts Med Ctr, Dept Med, Boston, MA USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA USA

[5] Baptist Hlth South Florida, Miami Cardiac & Vasc Inst, Miami, FL USA

关键词: myocardial infarction;    prevention;    risk;    statin;    young adults;   

DOI  :  10.1016/j.jacc.2017.11.007

来源: Elsevier

【 摘 要 】

BACKGROUND Despite significant progress in primary prevention, the rate of MI has not declined in young adults. OBJECTIVES The purpose of this study was to evaluate statin eligibility based on the 2013 American College of Cardiology/American Heart Association guidelines for treatment of blood cholesterol and 2016 U. S. Preventive Services Task Force recommendations for statin use in primary prevention in a cohort of adults who experienced a first-time myocardial infarction (MI) at a young age. METHODS The YOUNG-MI registry is a retrospective cohort from 2 large academic centers, which includes patients who experienced an MI at age # 50 years. Diagnosis of type 1 MI was adjudicated by study physicians. Pooled cohort risk equations were used to estimate atherosclerotic cardiovascular disease risk score based on data available prior to MI or at the time of presentation. RESULTS Of 1,685 patients meeting inclusion criteria, 210 (12.5%) were on statin therapy prior to MI and were excluded. Among the remaining 1,475 individuals, the median age was 45 years, there were 294 (20%) women, and 846 (57%) had ST-segment elevation MI. At least 1 cardiovascular risk factor was present in 1,225 (83%) patients. The median 10-year atherosclerotic cardiovascular disease risk score of the cohort was 4.8% (interquartile range: 2.8% to 8.0%). Only 724 (49%) and 430 (29%) would have met criteria for statin eligibility per the 2013 American College of Cardiology/ American Heart Association guidelines and 2016 U. S. Preventive Services Task Force recommendations, respectively. This finding was even more pronounced in women, in whom 184 (63%) were not eligible for statins by either guideline, compared with 549 (46%) men (p < 0.001). CONCLUSIONS The vast majority of adults who present with an MI at a young age would not have met current guideline-based treatment thresholds for statin therapy prior to their MI. These findings highlight the need for better risk assessment tools among young adults. (c) 2018 by the American College of Cardiology Foundation.

【 授权许可】

Free